InsidersTradesSigma
에이비엘바이오 Stock: price and insider trades · South Korea · DART (FSS)
Track the 에이비엘바이오 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 에이비엘바이오 has logged 69 reports. Market capitalisation: €5,089.3bn. The latest transaction was filed on 6 July 2026 (Other). Among the most active insiders: LEESANGHOON. All data is accessible without an account.
69
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
31 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 에이비엘바이오 Buy (bullish), based on 4 analysts. Average price target: ₩257,500.
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,961 of 25,451 companies
35.1
score / 100
Value31
Quality40
FCF yld-1.2%
Earn yld-0.7%
EV/EBITDA·
ROE-15%
Gross mgn100%
Net mgn-48%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 July 2026
Declarations69 total
0KRXDART:20260403003473
21,000 sharesKRXDART:20241008000559
2,316,762 sharesKRXDART:20240905000405
8,000 sharesKRXDART:20240830002194
4,408,440 sharesKRXDART:20240719000482
Ideal exit: 8 Apr 2025 (T+270)
0KRXDART:20240705000157
8,000 sharesKRXDART:20240701000228
8,000 sharesKRXDART:20231006000533
25 of 69 declarations
About 에이비엘바이오
Listed on the XKRX market, ABLE Bio specializes in the healthcare and pharmaceutical sector. The company focuses on developing innovative treatments for various diseases.